124 filings
Page 6 of 7
8-K
wy8czw d497xln
12 Feb 21
Fusion Pharmaceuticals Appoints Philina Lee, Ph.D., to
4:16pm
8-K
9pz6t7dfrvn9i030a
10 Nov 20
Fusion Pharmaceuticals Announces Third Quarter 2020 Financial Results
7:15am
8-K
xay68t9r5dazu
3 Nov 20
Fusion Pharmaceuticals Appoints Barbara Duncan as Chairperson of the Board of Directors
4:10pm
8-K
dejd057y9rt8n3ndq
2 Nov 20
Entry into a Material Definitive Agreement
7:11am
10-Q
6460gsd1qh
11 Aug 20
Quarterly report
4:05pm
8-K
3g7kgt
11 Aug 20
Fusion Pharmaceuticals Announces Second Quarter 2020 Financial Results
8:30am
S-8
qg9hzfe gzq2
30 Jun 20
Registration of securities for employees
4:35pm
8-K
6xyfraw96iy5 hv
30 Jun 20
Amendments to Articles of Incorporation or Bylaws
4:01pm
424B4
g77984
26 Jun 20
Prospectus supplement with pricing info
4:47pm
EFFECT
nj3l5ccv
26 Jun 20
Notice of effectiveness
12:15am
CERT
y93dpif28yy7677
25 Jun 20
Certification of approval for exchange listing
11:50am
8-A12B
bdp4 swv10y8
23 Jun 20
Registration of securities on exchange
4:04pm
CORRESP
nqju2 w7x
23 Jun 20
Correspondence with SEC
12:00am
CORRESP
zfmbt23v
23 Jun 20
Correspondence with SEC
12:00am
S-1/A
9blsf au7
22 Jun 20
IPO registration (amended)
6:16am
CORRESP
f1f3oe
10 Jun 20
Correspondence with SEC
12:00am
S-1
qm063 tr3xy9p
5 Jun 20
IPO registration
4:16pm
DRS/A
idp0sr32h7 eib
19 May 20
Draft registration statement (amended)
12:00am